STING1 and psoriasis: In mouse models, a psoriasis-like skin lesion induced by the topical application of a TLR7 agonist, imiquimod, is exacerbated by systemic injection of 5, 6-Dimethylxanthenone-4-acetic acid (DMXAA), a small molecule STING agonist [5].